Unblocking Australia’s biotech bottleneck: how AusHealth translates radical ideas into real-world treatments
Revealed: some of Australia’s most exciting biotech breakthroughs
In a podcast out today, AusHealth’s COO Justin Coombs sits down with Daniel Franco from Synergy IQ to talk pioneering research and how it’s being translated into Australia’s newest biotech companies.
Justin discusses the business of freeing Australia’s ‘bottleneck of biotechs’ and shares some of Australia’s newest medical therapies – therapies, he says, that are already changing lives…
Click the link to hear about:
· The remarkable story of Emily Whitehead, the first child to be treated with CAR T-cell therapy – she went from palliative care to cancer-free in just 30 days
· The founding of Carina BioTech – Australia’s first home-grown CAR-T cancer therapy to make it to a clinical trial, fully evolving ‘from the bench to the bedside’
· The groundbreaking septic shock therapy being developed at the Royal Adelaide Hospital thanks to a newly discovered blood protein
· The incredible story of Platypep, the project that’s building on platypus venom in a bid to create an ‘Australian Ozempic’
· The new AusHealth Phage Therapy Centre, dedicated to using engineered virus particles to treat drug-resistant infections
· The AI team developing a new system to convert mountains of hospital data into useful information for clinicians – already being tested in one of Australia’s busiest ICUs
· The trade-off between risk and reward when it comes to commercialising research
· And why failure really is an option!